Advance Enzymes rolls out chemical-free COVID immunity support bundle—‘ImmunoSEB’ and ‘Biome Ultra’

Mumbai, August 24, 2021: The COVID-19 pandemic has seen Mumbai-based specialty biotech company — Advanced Enzymes Technologies Ltd (NSE: ADVENZYMES; BSE: 540025) riding the new normal.

To ramp up sales of its researched-backed chemical-free post-COVID adaptive immune support bundle — ImmunoSEB and Biome Ultra (ProbioSEB CSC3), the company has beefed up its omnichannel presence across India and globally.

After tasting its runaway success in the US markets amidst the pandemic, AET decided to list its flagship immune support brands — ImmunoSEB and Biome Ultra, across online marketplaces in India to target a larger swath of pill-fatigued, healthy agers, immunity conscious millennials, and Gen Z.

The products are currently available globally on the leading e-commerce marketplace — Amazon. In a move to further shore up its direct-to-customer (D2C) omnichannel retailing business, AET is all set to unveil its online store — ‘Advanced Enzymes e-Direct Store’ in September 2021 to help customers choose from a wide range of health support products.

Tailored it to the local context, it’s currently working on various smart pivots and strategies to garner the share of silver linings in a bleak pandemic situation.

The company has invested in a big way to create captivated and customer-friendly user interfaces that offer the real omnichannel experience for young tech-savvy health conscious customers.

ImmunoSEB and Biome Ultra (ProbioSEB CSC3) comprise systemic enzymes and probiotics, which help in strengthening immunity and are most effective in reducing ‘long COVID’ afflictions.

ImmunoSEB is a systemic proteolytic enzyme supplement containing extracts from papayas and pineapples. Papaya contains papain enzyme, while bromelain is found in fresh pineapples.

It helps in rejuvenating cells, tissues, and organs alleviate inflammation and fatigue. Similarly, Biome Ultra is a probiotics formulation which is a formulation of healthy bacillus species strains. It helps in destroying toxins, improves imbalance of gut microflora, and enhances digestion & absorption of nutrients.

Soon after the online launch, the company witnessed a double-digit surge in demand for its probiotic products in the US markets, thanks to the rising awareness of gastrointestinal and immune healthcare, said Mr. MukundMadhusudanKabra, Whole-Time Director,Advanced Enzyme Technologies Limited.

Though the probiotics market is witnessing gradual growth globally, India remains mostly underpenetrated. According to Mr. Kabra, there is a strong demand for chemical free and clinically proven immune-boosting supplements from society’s middle and upper strata.

The lack of remedy for chronic diseases and side-effects of standard medicines are forcing people to rush towards healthier, natural, and chemical-free adaptive immune therapies like ImmunoSEB and Biome Ultra.

Research indicates immense growth in India’s probiotics market in the next three to four years. It’s expected to grow at a CAGR of 13.56 percent to notch up a market size of $961.856 million by the end of 2025. It currently stands at $448.456 million, said Dr. Abhijit K. Rathi, Principal Scientist, AET.

According to the famous Greek physician Hippocrates of Kos, also known as the ‘father of medicine’ and accredited with conceiving the ‘Hippocratic Oath,’ once alluded saying: ‘All diseases originate in the gut.’

“One of the pivotal players in the immune health system is the gut, which is perpetually open to toxins and alien antigens stemming from microbes and food. The gut is the key immune organ in the body. Strangely, it largely remains an elapsed organ in the overall health system till date. There are over 3,000 bacterial species that inhabit the gut, which has a synergetic relationship with the human body and also known as gut-brain axis (GBA). Likewise, there are trillions of bacteria in our gut that shapes ecology similar to a ‘flower garden,” elucidated Dr.Rathi.

“The cost of COVID-19 treatment indicated how financially disastrous and crippling an illness could be. Cost of hospitalization has become something everyone wants to avoid, and people have realized it is best to adopt preventive measures,” he said.

“While the world is beleaguered with the devastating virus each day, no medicine vows absolute protection, and vaccination seems to be the only possible option at the moment. We at AET are extensively conducting innovative research on chemical free methods to enhance the immunity, which can help your body fight the rapidly mutatingvirus with each passing day,” said Dr.Rathi.

Meanwhile, AET plans to introduce more enzymes and probiotics products in its kitty in various genres, including human nutrition for immunity development, functional health food, gut health, and various nutraceutical applications. The company is determined to launch additional products on immunity development and digestion improvement to elevate nutritional levels in feeds in the animal nutrition segment.

Corporate Comm India (CCI NewsWire)